CClinicalTrials.gg
CompletedNCT07794696Updated Sep 1, 2026

Family Videos and Virtual Reality in Intensive Care Patients

An interventional study of Family Video.Participants watched a five-minute video prepared by their family members twice daily on the second and third days of intensive care. in Anxiety, Agitation and Pain, sponsored by Sennur Kula Şahin. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by Sennur Kula Şahin · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This randomized controlled trial was conducted to evaluate the effects of family videos and virtual reality-based nature videos on anxiety, agitation, pain, and vital signs in adult intensive care unit patients. A total of 72 participants were randomly assigned to three parallel groups: a family video group (n=24), a family video plus virtual reality-based nature video group (n=24), and a standard care control group (n=24). Anxiety, agitation, pain, and vital signs were assessed before and after the interventions during the second and third days of intensive care.

Read the detailed description

Intensive care unit patients may experience psychological and physiological problems such as anxiety, agitation, and pain because of the stressful and isolating nature of the intensive care environment. This randomized controlled trial evaluated family-based visual support and virtual reality-based nature videos as non-pharmacological supportive interventions in adult intensive care unit patients.

Participants were randomly assigned to one of three parallel groups. In the first intervention group, participants watched five-minute family videos twice daily. In the second intervention group, participants watched five-minute family videos twice daily and additionally viewed nature-themed videos using a virtual reality headset once daily for approximately 15-20 minutes. Participants in the control group received standard treatment and nursing care without a study-specific video or virtual reality intervention.

The interventions and assessments were performed on the second and third days of intensive care after the patients' clinical condition had been evaluated and approved by a physician. Anxiety, agitation, and pain were assessed immediately before and after the interventions. Vital signs were obtained from routine clinical monitoring records. During virtual reality sessions, the researcher remained with the participant and monitored for possible adverse effects such as dizziness

02

Conditions studied

  • Anxiety
  • Agitation
  • Pain
  • Physiological Parameters
  • Intensive Care

Keywords

  • Intensive Care Unit
  • Family Video
  • Family Support
  • Virtual Reality
  • Nature Video
  • Anxiety
  • Agitation
  • Pain
  • Vital Signs
  • Nonpharmacological Intervention
03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Aged 18-80 years

  • Hospitalized in an intensive care unit
  • Conscious and able to communicate
  • Willing to participate in the study
  • At least literate
  • Able to speak Turkish
  • No diagnosed psychiatric disorder
  • Hospitalized in the intensive care unit for at least two days

Exclusion criteria

Exclusion Criteria:

Visual or hearing impairment

  • Being intubated
  • Cognitive, sensory, or verbal impairment preventing communication
  • Use of sedative, anxiolytic, or similar medications
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    Family Video Intervention

    Family Video Intervention:Participants watched five-minute family videos twice daily on the second and third days of intensive care. Anxiety, agitation, pain, and vital signs were assessed immediately before and after the intervention.

    Behavioral: Family Video.Participants watched a five-minute video prepared by their family members twice daily on the second and third days of intensive care.

  • Experimental
    Family Video +Virtual Reality Group

    Family Video Plus Virtual Reality Group. Participants watched five-minute family videos twice daily and additionally viewed nature-themed videos using a virtual reality headset once daily for 15-20 minutes on the second and third days of intensive care. Anxiety, agitation, pain, and vital signs were assessed before and after the interventions.

    Behavioral: Family Video.Participants watched a five-minute video prepared by their family members twice daily on the second and third days of intensive care.

  • No intervention
    Standard Care Control

    Standard Care Control Group. Participants received standard treatment and nursing care without a study-specific family video or virtual reality intervention. Outcomes were assessed at the same times and frequency as in the intervention groups.

Interventions

  • BehavioralFamily Video.Participants watched a five-minute video prepared by their family members twice daily on the second and third days of intensive care.

    Participants viewed nature-themed video content using a virtual reality headset for approximately 15-20 minutes once daily on the second and third days of intensive care. The researcher remained with participants during the session and monitored for possible adverse effects.

05

What researchers measure

Primary outcomes

  1. State Anxiety Level

    State anxiety was assessed using the State-Trait Anxiety Inventory-State (STAI-I). The scale consists of 20 items, with total scores ranging from 20 to 80. Higher scores indicate higher levels of state anxiety.

    Time frame: Immediately before and after the intervention sessions on intensive care unit days 2 and 3.

Secondary outcomes

  1. Agitation-Sedation Level

    Agitation and sedation were assessed using the Richmond Agitation-Sedation Scale (RASS), which ranges from -5 to +4. Positive scores indicate increasing levels of agitation, 0 indicates an alert and calm state, and negative scores indicate increasing levels of sedation.

    Time frame: Immediately before and after the intervention sessions on intensive care unit days 2 and 3.

Other outcomes

  1. Pain Intensity

    Pain intensity was assessed using a Numerical Pain Rating Scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the most severe pain.

    Time frame: Immediately before and after the intervention sessions on intensive care unit days 2 and 3.

  2. Heart Rate

    Description: Heart rate was recorded before and after the intervention sessions. Time Frame: Immediately before and after the intervention sessions on intensive care unit days 2

    Time frame: Immediately before and after the intervention sessions on intensive care unit days 2 and 3.

  3. Respiratory Rate

    Respiratory rate was recorded before and after the intervention sessions.

    Time frame: Immediately before and after the intervention sessions on intensive care unit days 2 and 3.

  4. Systolic Blood Pressure

    Systolic blood pressure was recorded before and after the intervention sessions.

    Time frame: Immediately before and after the intervention sessions on intensive care unit days 2 and 3.

  5. Diastolic Blood Pressure

    Diastolic blood pressure was recorded before and after the intervention sessions.

    Time frame: Immediately before and after the intervention sessions on intensive care unit days 2 and 3.

  6. Body Temperature

    Body temperature was recorded before and after the intervention sessions.

    Time frame: Immediately before and after the intervention sessions on intensive care unit days 2 and 3.

06

Study locations

1 site
  • Istanbul Ministry of Health Goztepe Training and Research Hospital
    Istanbul, Istanbul 34010, Turkey (Türkiye)
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07794696
Lead sponsor
Sennur Kula Şahin
Responsible party
Sennur Kula Şahin (Assoc.Prof, Istinye University) — Sponsor-investigator
First posted
Aug 31, 2026
Start date
Oct 20, 2024
Primary completion
Mar 25, 2025
Completion
Mar 25, 2025
Last update
Sep 1, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion